Suppression effects on body weight and fat of calcium alginate in healthy adults
Not Applicable
- Conditions
- metabolic syndrome
- Registration Number
- JPRN-UMIN000019658
- Lead Sponsor
- Takasaki University of Health and Welfare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Those who felt this study was inconvenient to everyday life.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect on body weight (Measuring point:every week)
- Secondary Outcome Measures
Name Time Method The effect on body fat (Measuring point: every week)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain calcium alginate's weight suppression effects in metabolic syndrome?
How does calcium alginate compare to standard-of-care treatments for metabolic syndrome in weight management?
Are there specific biomarkers that predict individual response to calcium alginate in metabolic syndrome patients?
What are the potential adverse events associated with calcium alginate supplementation in healthy adults?
What related compounds or combination therapies show synergistic effects with calcium alginate for body fat reduction?